Home
Krishna Vaddi, CEO: Prelude Therapeutics PRLD Buy · Filed 25/03/18
Trade details
- Type
- Insider buy
- Amount
- $6,829.5
- Shares · price
- 9,106 sh · $0.75 a share
- Held after
- 1,303,880 sh
- Person
- Krishna VaddiCEO
- Trade date
- 25/03/17
- Filed
- 25/03/18
- Days to filing
- 1 days
First buy since 2023
- Insiders buying this week
- 1 insiders
- Holding change
- +0.7%
Prelude Therapeutics trades, last 26 weeks
What else happened in Prelude Therapeutics around then
Filed or reported within 30 days of the trade day · 25/02/15~25/04/16Krishna Vaddi's recent trades
- Krishna Vaddi
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$465.8K
675,000 sh
$465.8K
Filed 25/03/27
Traded 25/03/25
- Krishna Vaddi
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$11K
15,000 sh
$11K
Filed 25/03/24
Traded 25/03/21
- Krishna Vaddi
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$3,954
5,416 sh
$3,954
Filed 25/03/24
Traded 25/03/20
- Krishna Vaddi
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$22.5K
29,999 sh
$22.5K
Filed 25/03/18
Traded 25/03/14
- Krishna Vaddi
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$36K
50,000 sh
$36K
Filed 25/03/14
Traded 25/03/13